SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-11-133821
Filing Date
2011-05-10
Accepted
2011-05-10 12:39:57
Documents
10
Period of Report
2011-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 685480
2 EXECUTIVE RETENTION BONUS AGREEMENT dex101.htm EX-10.1 18316
3 EXECUTIVE RETENTION BONUS AGREEMENT dex102.htm EX-10.2 18347
4 EXECUTIVE RETENTION BONUS AGREEMENT dex103.htm EX-10.3 18401
5 EXECUTIVE RETENTION BONUS AGREEMENT dex104.htm EX-10.4 18306
6 EXECUTIVE RETENTION BONUS AGREEMENT dex105.htm EX-10.5 18319
7 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 9680
8 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 9700
9 SECTION 906 CEO CERTIFICATION dex321.htm EX-32.1 3787
10 SECTION 906 CFO CERTIFICATION dex322.htm EX-32.2 3810
  Complete submission text file 0001193125-11-133821.txt   805152
Mailing Address 4222 EMPEROR BLVD STE 200 DURHAM NC 27703-8466
Business Address 4222 EMPEROR BLVD STE 200 DURHAM NC 27703-8466 9199419777
INSPIRE PHARMACEUTICALS INC (Filer) CIK: 0001040416 (see all company filings)

IRS No.: 043209022 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31577 | Film No.: 11826793
SIC: 2834 Pharmaceutical Preparations